SAFETY AND EFFICACY OF TWO TACROLIMUS FORMULATIONS (PROGRAF® AND ADVAGRAF®) IN MALAYSIAN RENAL TRANSPLANT PATIENTS: A COMPARATIVE STUDY
Journal of University of Malaya Medical Centre
;
: 20-26, 2019.
Artigo
em Inglês
| WPRIM
| ID: wpr-751173
ABSTRACT
@#A once-daily formulation of tacrolimus, Advagraf®, is increasingly being used in place of twice-daily tacrolimus, Prograf®, as a standard immunosuppressive agent for transplant patients. In this study, the clinical safety and efficacy of Advagraf® were compared with Prograf®, among multi-ethnic Malaysian renal transplanted population.
Buscar no Google
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Inglês
Revista:
Journal of University of Malaya Medical Centre
Ano de publicação:
2019
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS